Exclusive

Publication

Byline

Direct Relief Mobilizes Global Medical Aid for Disaster Recovery and Maternal Health

India, July 20 -- In response to the June 2026 earthquakes in Venezuela, Direct Relief has mobilized multimillion dollar medical aid shipments and specialized mobile teams to provide essential healthc... Read More


Monsoon Session Begins: BJD Backs Smooth Parliament Functioning but Vows to Raise Odisha's Key Issues

Bhubaneswar, July 20 -- As the high-stakes Monsoon Session of Parliament commenced on Monday, the political divide between the ruling National Democratic Alliance (NDA) and the Opposition was on full ... Read More


Jindal Stainless Forms An Ascending Triangle Pattern Hinting At A Near-Term Bullish Breakout

India, July 20 -- An ascending triangle is a bullish reversal pattern marked by higher lows and a flat resistance line. The chart shows a confirmed bullish breakout above the resistance neckline. Supp... Read More


Speaker Gupta named to AIPOC committee

India, July 20 -- Delhi Legislative Assembly Speaker Vijender Gupta has been nominated as a member of a high-level committee constituted by the All India Presiding Officers' Conference (AIPOC) to deve... Read More


UPDATED: Another American soldier killed as US, Iran continue strikes

Nigeria, July 20 -- A US soldier has been killed in Iraq, bringing to 17 the number of American soldiers who have been confirmed killed in the war with Iran. The US Central Command (CENTCOM) announce... Read More


Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared with Pembrolizumab monotherapy in participants with advanced colorectal adenocarcinoma (CRC) harboring microsatellite instability (MSI) and/or deficient mismatch repair (DMMR)

Singapore, July 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherapy (modified FOLFIRINOX or Gemcitabine plus Nab-paclitaxel) with or without Zoldonrasib (RMC 9805) as First-line Treatment in Patients with Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma (RASolute 305)

Singapore, July 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemothera... Read More


Singapore Clinical Trial: A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Study to Evaluate the Gastric Emptying Delay, Pharmacokinetics, Safety, and Tolerability of Eloralintide in Participants with Obesity or Overweight

Singapore, July 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose St... Read More


Singapore Clinical Trial: A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating the safety and tolerability of ARD001 in healthy adult subjects and a Phase 2 open-label, multiple-dose study in adult subjects with hemophilia A

Singapore, July 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More


Singapore Clinical Trial: A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder

Singapore, July 20 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More